Taurine interferes with spiperone binding in the striatum.
P Kontro, S S Oja
Index: Neuroscience 19(3) , 1007-10, (1986)
Full Text: HTML
Abstract
The effects of taurine and its structural analogues and two new anticonvulsant derivatives, taltrimide and MY-103, on the function of brain dopaminergic systems were studied by assessing their interference with the binding of [3H]spiperone to synaptic membranes isolated from rat striata. Two populations of binding sites were detected. The binding was effectively displaced by (+)butaclamol and dopamine, serotonin being less potent by one order of magnitude. Taurine, taltrimide and MY-103 inhibited spiperone binding moderately. The binding constants of both high- and low-affinity components and the maximal binding capacity of the low-affinity component decreased in the presence of taurine. The results show that taurine and its novel anticonvulsant derivates could modulate the function of striatal dopaminergic systems.
Related Compounds
Related Articles:
2013-02-01
[Eukaryotic Cell 12(2) , 278-87, (2013)]
Inhibition of platelet thromboxane generation by suloctidil in man.
1986-01-01
[Haemostasis 16(5) , 362-8, (1986)]
1988-01-01
[J. Clin. Chem. Clin. Biochem. 26(1) , 3-6, (1988)]
Suloctidil-induced hepatotoxicity.
[Gastroenterology 95(2) , 490-1, (1988)]
Suloctidil hepatitis: a case presentation.
1987-10-01
[Ir. J. Med. Sci. 156(10) , 290-1, (1987)]